MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about disclosure

29 Jul 2021 Evaluate
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, Jagsonpal Pharmaceuticals has informed that it enclosed disclosure of Related Party Transaction, in the format specified in the Accounting Standard for the financial year ended March 31st, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..